Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NCGC00229600 is an allosteric inverse thyrotropin receptor (TSHR) agonist. NCGC00229600 inhibits both TSH and stimulating antibody activation of TSHRs endogenously and can be used in Graves' disease studies.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 125.00 | |
5 mg | In stock | $ 313.00 | |
10 mg | In stock | $ 497.00 | |
25 mg | In stock | $ 793.00 | |
50 mg | In stock | $ 1,130.00 | |
100 mg | In stock | $ 1,520.00 | |
500 mg | In stock | $ 2,970.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 345.00 |
Description | NCGC00229600 is an allosteric inverse thyrotropin receptor (TSHR) agonist. NCGC00229600 inhibits both TSH and stimulating antibody activation of TSHRs endogenously and can be used in Graves' disease studies. |
Molecular Weight | 479.57 |
Formula | C30H29N3O3 |
CAS No. | 1338824-20-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (93.83 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NCGC00229600 1338824-20-6 GPCR/G Protein Others TSH Receptor disease cAMP Inhibitor Thyroid-stimulating hormone Receptor fibroblasts endogenously Thyrotropin receptor NCGC-00229600 antibody NCGC 00229600 Graves inhibit inhibitor